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Drug Testing and Residue 




(Drug Testing & Toxicology)
Overview of the DTL
• Established in 1989
• Legislative direction to provide 
drug testing for pari-mutuel 
horse racing
• ~2,800 blood and urine 
samples annually
• 1992
• Legislative direction to 
provide drug testing 
for pari-mutuel 
greyhound racing
• ~400 urine samples 
annually
• Between 1989 - 1992
• Began providing drug testing 
for livestock shows and county 
fairs
• ~3,200 samples annually
Other Services (tvmdl.tamu.edu) 






• Split Sample Testing
• Drugs of Abuse




• Equine Hair Drug Screen
• Ractopamine, Clenbuterol, 
Zilpaterol, Albuterol
• General Drug Screen
Drug Testing in Show Animals
Why Testing is Important








What Do We Test For??
• NSAIDs












• Herbal and All-Natural Products














• All data is reviewed by at least two individuals
• Results are reported directly to the show
• Qualitative vs. Quantitative
• Interpretation – incidental vs. intentional
• Sample retention:
• Negative samples retained refrigerated for ~ 2weeks after reporting
• Positive samples retained frozen for 1 year
• Records are retained for 2 years
Advancements in Technology
Why??
• Regulatory Testing for the Horse Racing Industry
• Required to achieve sensitivity to detect therapeutic drugs
• i.e. Dexamethasone at 5 pg/mL in blood
• Required to achieve accreditation
• American Association for Laboratory Accreditation (A2LA) – ISO 17025
• Racing Medication & Testing Consortium (RMTC)
Applied to Livestock Show Testing
• Improved sensitivity
• Increased sample throughput
• Reduction in false positives at screening
• Elimination of “masking agents”
• Ability to add/remove drugs quickly
• Increased automation


















1999 - 2011 2012 2013 2014 2015 2016
Annual # of Positive Findings per Species (Urine)
[Total # Tested = 29,287]
Bovine Porcine Caprine Ovine
What about therapeutic drugs?
Zero Tolerance
• “Zero” = the limits of detection of the method used for screening
• TLC ~250 ppb
• ELISA ~1-10 ppb
• LC-MS ~0.01 ppb
• Consideration of classification of Zero Tolerance
• Illicit drugs



























Flunixin Concentrations in Urine (2016-2017)
Therapeutic Drugs
• Concentration differences between therapeutic and performance-
enhancing effect
• Difficult to measure in a show animal
• Requires quantitation
• Establish withdrawal guidelines in serum/urine
• Research related
• Establish screening threshold levels
• Research related
How to Adjust to 
Advancements in Testing 
Capabilities
• Know the show’s policies on drug use
• Work with a veterinarian
• Follow the label
• Keep detailed records
• Utilize resources
• County extension agents
• Representatives from the show
• Texas A&M AgriLife Extension
• TVMDL
• FARAD (www.farad.org) 
• FDA (https://animaldrugsatfda.fda.gov) 




• Veterinarians need to be able to provide good guidance to their clients 
with show animals that does not jeopardize their ability to enter shows 
at the expense of animal health.
• There is a need to be able to defend this approach to the shows, and 
demonstrate how to approach governance of drug use with useful and 
evidence-based methods.




• PK study of Flunixin and 
Meloxicam in pigs and goats
• Urine, blood and liver samples 




• PK study of Flunixin and 
Meloxicam in cattle
• Urine, blood and liver samples 
collected at multiple time 
points
Goals and Objectives
• Determine when urine residues of flunixin and meloxicam are 
below detectable levels
• Determine a conservative urine withdrawal time for these two 
drugs with statistical confidence
• Develop predictive models for estimating urine withdrawal time if 
these drugs were to be used at extra-label doses
• Provide preliminary data for conducting similar studies for other 
therapeutic drugs used in show animals 
Descriptive Review of Drug 




































Total Out of State In State
Total Number of Shows from 1999 – 2016
Confirmed Drugs in Retina by Species from 1999-2016
Bovine Porcine Ovine Caprine
Clenbuterol 0 3 6 1
Zilpaterol 2 9 13 5
Ractopamine 1 8 0 2













1999 - 2011 2012 2013 2014 2015 2016
Annual # of Positive Findings per Species (Urine)




















Flunixin Concentrations in Urine (2016-2017)
Hair Testing
Overview
• Broader window of detection 
compared to serum and urine
• Easy collection and non-invasive
• Potential to estimate time of drug 
administration
• Currently performed at TVMDL in 
horses
• Already collected at some shows for 
DNA testing
Broader Window of Detectability
• Serum and urine are within hours 
and up to several days
• Some drugs can be detected in hair 
up to 1 year after administration
• Retina is effective but only 
available from terminal animals










• Hair color matters
• Location of hair on body
• Contamination issues
• Rate of hair growth in various species
• Retention time of drugs in hair
• Lack of true positive controls
Summary
• Drug testing is an ever-changing process
• Improved analytical testing capabilities
• New drugs and new old drugs
• New testing strategies and target molecules
• Stay informed of the show’s rules/policies
• Work with a veterinarian and keep detailed records
• Research efforts are underway to provide answers and 
interpretation
QUESTIONS?
“Aye God, Woodrow, it’s 
been quite a party, ain’t it?”
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